Study: NCT05398679

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cefaclor
Description: cefaclor intravenous 2 gr/day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin Tablets
Description: 500-750 mg/12 hrs (maximum 3g x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ciprofloxacin Injection
Description: 1200 mg/day maximum dose IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clindamycin Oral Capsule
Description: 600 mg/8 hours (maximum 1.800 mg x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clindamycin Injection
Description: 600 mg/8 hours (maximum 1.800 mg x day) IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dicloxacillin Oral Capsule
Description: 1g/8 hours (maximum 4 gr day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dicloxacillin
Description: 1g/8 hours (maximum 4 g x day) IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fusidic Acid Only Product in Oral Dose Form
Description: 0,750g/12 hours (maximum 1,5 g x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fusidic Acid Only Product in Parenteral Dose Form
Description: 0,75 g/12 hours (maximum 1,5 g x day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofloxacin Oral Tablet
Description: 0.5g/12-24hours (maximum 1 g x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levofloxacin Injection
Description: 0.5g/12-24hours (maximum 1 g x day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linezolid Oral Tablet
Description: 0,6 g/12 hours (maximum 1200 mg x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Linezolid Injectable Product
Description: 0,6 g/12 hours (maximum 1200 mg x day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin tablet
Description: 0,4 g/day (maximum 400 mg x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin Injectable Product
Description: 0,4 g/day (maximum 400 mg x day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin Only Product in Oral Dose Form
Description: 0,3-0,5 g/12 hours (maximum 1200 mg x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rifampicin Only Product in Parenteral Dose Form
Description: 0,3-0,6 g/12 hours (maximum 1200 mg x day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim]
Description: sulfamethoxazole 1600 mg/trimethoprin 320 mg (maximum x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sulfamethoxazole / Trimethoprim Injectable Product
Description: sulfamethoxazole 1600 mg/trimethoprin 320 mg (maximum x day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tedizolid Oral Tablet
Description: 200 mg tedizolid (maximum x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tedizolid Injection
Description: 200 mg (maximum x day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin Capsules
Description: 1 gr/6 hours (4 g x day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: 1 gr/6 hours (4 g x day) Intravenous

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefaclor Capsules
Description: 2 gr/day